ContraFect to Present New Clinical and Microbiological Data on CF-301 at ASM Microbe 2017 YONKERS, NY--(Marketwired - June 01, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...

Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial Pathogens Panel SALT LAKE CITY, June 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it will present three posters describing the...